News
Collection · newest first-
JP Morgan Says Post-IPO Success Starts With A Framework, Not A Transaction
JP Morgan’s Private Bank is advising founders, executives and early employees to resist making immediate investment decisions after an IPO, arguing that…
-
Reddit’s most-mentioned stocks today: Microsoft leads (29 Jul 2026)
Microsoft tops Reddit’s finance boards with 658 mentions in the past 24 hours. The full top 10, ranked by mentions across the…
-
Ocean Power Technologies Sets Up $20 Million At-The-Market Stock Offering
Ocean Power Technologies, Inc. has entered into an agreement to sell up to $20,000,000 of common stock through an at-the-market offering, according…
-
Noble Corp Posts Q2 Net Loss as Brazil Rig Suspensions Weigh on Results, Cuts Full-Year Guidance
Noble Corporation plc reported a second-quarter net loss of $37 million and said it is trimming its full-year 2026 revenue and earnings…
-
Vulcan Materials Says NAFTA Tribunal Found Mexico Violated Trade Pact but Awarded Negligible Damages
Vulcan Materials Company said in a filing with the SEC that a NAFTA arbitration tribunal has ruled Mexico violated the North American…
-
Axiom Intelligence Acquisition Corp 1 Secures Up to $1 Million Promissory Note
Axiom Intelligence Acquisition Corp 1 said in a filing with the Securities and Exchange Commission that it has entered into a promissory…
-
Rush Enterprises Reports Second-Quarter Revenue of $1.9 Billion, Announces Stock Split and Dividend Increase
Rush Enterprises, Inc. reported second-quarter 2026 revenues of $1.9 billion and net income of $72.8 million, or $0.91 per diluted share, according…
-
Cboe Global Markets Restates Credit Agreement, Extends Revolving Facility
Cboe Global Markets, Inc. entered into a Third Amended and Restated Credit Agreement with Bank of America, N.A. and a group of…
-
Reddit’s Most-Mentioned Stocks Today: SanDisk Leads (28 Jul 2026)
SanDisk (Now WDC) tops Reddit’s finance boards with 509 mentions in the past 24 hours. The full top 10, ranked by mentions…
-
Outlook Therapeutics Wins FDA Approval for LYTENAVA, First Ophthalmic Bevacizumab for Wet AMD
Outlook Therapeutics said in a filing that the U.S. Food and Drug Administration has approved LYTENAVA (bevacizumab-vikg) for the treatment of wet…